Optimizing stem cell function for the treatment of ischemic heart disease

Journal of Surgical Research

Volumn 166, Issue 1, 2011, Pages 138-145

  Herrmann, Jeremy L ^a   Abarbanell, Aaron M ^a   Weil, Brent R ^a   Manukyan, Mariuxi C ^a   Poynter, Jeffrey A ^a   Brewster, Benjamin J ^a   Wang, Yue ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

hypoxic preconditioning; myocardial ischemia; paracrine signaling; stem cell survival; stem cell therapy

Indexed keywords

ANGIOGENIN; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 18 BINDING PROTEIN; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN;

CELL FUNCTION; CELL HOMING; GENETIC MANIPULATION; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW;

GRAFT SURVIVAL; HUMANS; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA; PARACRINE COMMUNICATION; STEM CELL TRANSPLANTATION;

EID: 79951683552     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.05.057     Document Type: Review

References (96)

1. V. Schachinger, B. Assmus, and M.B. Britten Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final 1-year results of the TOPCARE-AMI Trial J Am Coll Cardiol 44 2004 1690
2. C. Heeschen, R. Lehmann, and J. Honold Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease Circulation 109 2004 1615
3. B. Assmus, U. Fischer-Rasokat, and J. Honold Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: Results of the TOPCARE-CHD Registry Circ Res 100 2007 1234
4. M.J. Lipinski, G.G. Biondi-Zoccai, and A. Abbate Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials J Am Coll Cardiol 50 2007 1761
5. G.P. Meyer, K.C. Wollert, and J. Lotz Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 2006 1287
6. T. Freyman, G. Polin, and H. Osman A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur Heart J 27 2006 1114
7. P.A. Conget, and J.J. Minguell Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells J Cell Physiol 181 1999 67
8. M. Di Nicola, C. Carlo-Stella, and M. Magni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838
9. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815
10. M.F. Pittenger, and B.J. Martin Mesenchymal stem cells and their potential as cardiac therapeutics Circ Res 95 2004 9
11. D. Orlic, J. Kajstura, and S. Chimenti Mobilized bone marrow cells repair the infarcted heart, improving function and survival Proc Natl Acad Sci U S A 98 2001 10344
12. C. Toma, M.F. Pittenger, and K.S. Cahill Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 2002 93
13. P.C. Hsieh, V.F. Segers, and M.E. Davis Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury Nat Med 13 2007 970
14. C.E. Murry, L.J. Field, and P. Menasche Cell-based cardiac repair: Reflections at the 10-year point Circulation 112 2005 3174
15. M. Gnecchi, H. He, and N. Noiseux Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 2006 661
16. T. Kinnaird, E. Stabile, and M.S. Burnett Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678
17. M. Wang, J. Tan, and Y. Wang IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction Proc Natl Acad Sci U S A 106 2009 17499
18. M. Gnecchi, H. He, and O.D. Liang Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat Med 11 2005 367
19. P.R. Crisostomo, A.M. Abarbanell, and M. Wang Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions Am J Physiol Heart Circ Physiol 295 2008 H1726
20. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124
21. Z. Cai, D.J. Manalo, and G. Wei Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79
22. T. Date, S. Mochizuki, and A.J. Belanger Expression of constitutively stable hybrid hypoxia-inducible factor-1α protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury Am J Physiol Cell Physiol 288 2005 C314
23. Z. Cai, H. Zhong, and M. Bosch-Marce Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α Cardiovasc Res 77 2008 463
24. H. Kawata, K. Yoshida, and A. Kawamoto Ischemic preconditioning up-regulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium Circ Res 88 2001 696
25. M.I. Niagara, H. Haider, and S. Jiang Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart Circ Res 100 2007 545
26. M. Kubo, T.S. Li, and R. Suzuki Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance Am J Physiol Heart Circ Physiol 294 2008 H590
27. I. Rosova, M. Dao, and B. Capoccia Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells Stem Cells 26 2008 2173
28. X. Hu, S.P. Yu, and J.L. Fraser Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis J Thorac Cardiovasc Surg 135 2008 799
29. H. Won Kim, H.K. Haider, and S. Jiang Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2 J Biol Chem 284 2009 33161
30. H. Haider, S. Jiang, and N.M. Idris IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair Circ Res 103 2008 1300
31. K. Pillarisetti, and S.K. Gupta Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1α mRNA is selectively induced in rat model of myocardial infarction Inflammation 25 2001 293
32. A.T. Askari, S. Unzek, and Z.B. Popovic Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697
33. A. Kortesidis, A. Zannettino, and S. Isenmann Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells Blood 105 2005 3793
34. Z. Pasha, Y. Wang, and R. Sheikh Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium Cardiovasc Res 77 2008 134
35. M. Zhang, N. Mal, and M. Kiedrowski SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction FASEB J 21 2007 3197
36. Z. Cheng, L. Ou, and X. Zhou Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance Mol Ther 16 2008 571
37. J. Guo, G. Lin, and C. Bao Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction J Biomed Sci 15 2008 89
38. Y. Li, X. Yu, and S. Lin Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells Biochem Biophys Res Commun 356 2007 780
39. D.W. Losordo, P.R. Vale, and J.F. Symes Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800
40. T. Funatsu, Y. Sawa, and S. Ohtake Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor J Thorac Cardiovasc Surg 124 2002 1099
41. V. van Weel, R.B. van Tongeren, and V.W. van Hinsbergh Vascular growth in ischemic limbs: A review of mechanisms and possible therapeutic stimulation Ann Vasc Surg 22 2008 582
42. R. Laguens, P. Cabeza Meckert, and G. Vera Janavel Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer Gene Ther 9 2002 1676
43. T. Asahara, T. Takahashi, and H. Masuda VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO J 18 1999 3964
44. K. Hiasa, K. Egashira, and S. Kitamoto Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor Basic Res Cardiol 99 2004 165
45. Y.L. Tang, Q. Zhao, and Y.C. Zhang Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium Regul Pept 117 2004 3
46. M.J. Guzman, P.R. Crisostomo, and M. Wang Vascular Endothelial Growth Factor Improves Myocardial Functional Recovery Following Ischemia/Reperfusion Injury J Surg Res 2008
47. S.Y. Lim, Y.S. Kim, and Y. Ahn The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model Cardiovasc Res 70 2006 530
48. M. Wang, P.R. Crisostomo, and C. Herring Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism Am J Physiol Regul Integr Comp Physiol 291 2006 R880
49. T.A. Markel, Y. Wang, and J.L. Herrmann VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function Am J Physiol Heart Circ Physiol 295 2008 H2308
50. Y. Wang, H.K. Haider, and N. Ahmad Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair J Mol Cell Cardiol 40 2006 736
51. J. Yang, W. Zhou, and W. Zheng Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction Cardiology 107 2007 17
52. K. Kurachi, E.W. Davie, and D.J. Strydom Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor Biochemistry 24 1985 5494
53. A. Hartmann, M. Kunz, and S. Kostlin Hypoxia-induced up-regulation of angiogenin in human malignant melanoma Cancer Res 59 1999 1578
54. S.D. Huang, F.L. Lu, and X.Y. Xu Transplantation of angiogenin- overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia J Thorac Cardiovasc Surg 132 2006 1329
55. K.G. Shyu, O. Manor, and M. Magner Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb Circulation 98 1998 2081
56. I. Kim, H.G. Kim, and S.O. Moon Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion Circ Res 86 2000 952
57. J. Shujia, H.K. Haider, and N.M. Idris Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair Cardiovasc Res 77 2008 525
58. H.F. Duan, C.T. Wu, and D.L. Wu Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor Mol Ther 8 2003 467
59. Z. Mallat, C. Heymes, and A. Corbaz Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure FASEB J 18 2004 1752
60. N. Gerdes, G.K. Sukhova, and P. Libby Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for atherogenesis J Exp Med 195 2002 245
61. P.R. Woldbaek, T. Tonnessen, and U.L. Henriksen Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction Cardiovasc Res 59 2003 122
62. D.R. Meldrum Tumor necrosis factor in the heart Am J Physiol 274 1998 R577
63. R.E. Iosif, C.T. Ekdahl, and H. Ahlenius Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis J Neurosci 26 2006 9703
64. T.A. Markel, P.R. Crisostomo, and M. Wang Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production Am J Physiol Gastrointest Liver Physiol 293 2007 G657
65. S. Schutze, V. Tchikov, and W. Schneider-Brachert Regulation of TNFR1 and CD95 signalling by receptor compartmentalization Nat Rev Mol Cell Biol 9 2008 655
66. P.R. Crisostomo, M. Wang, and C.M. Herring Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1) J Mol Cell Cardiol 42 2007 142
67. L. Marchetti, M. Klein, and K. Schlett Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-κ B pathway J Biol Chem 279 2004 32869
68. P.R. Crisostomo, Y. Wang, and T.A. Markel Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NF-κ B but not JNK-dependent mechanism Am J Physiol Cell Physiol 294 2008 C675
69. D. Ait-Ali, V. Turquier, and Y. Tanguy Tumor necrosis factor (TNF)-α persistently activates nuclear factor-κB signaling through the type 2 TNF receptor in chromaffin cells: Implications for long-term regulation of neuropeptide gene expression in inflammation Endocrinology 149 2008 2840
70. C. Bao, J. Guo, and G. Lin TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI Scand Cardiovasc J 42 2008 56
71. T.F. Franke, D.R. Kaplan, and L.C. Cantley PI3K: Downstream AKTion blocks apoptosis Cell 88 1997 435
72. M. Zhang, D. Methot, and V. Poppa Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies J Mol Cell Cardiol 33 2001 907
73. A.A. Mangi, N. Noiseux, and D. Kong Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts Nat Med 9 2003 1195
74. G.C. Fan, X. Zhou, and X. Wang Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity Circ Res 103 2008 1270
75. J.G. Ghosh, A.K. Shenoy Jr., and J.I. Clark Interactions between important regulatory proteins and human αB crystallin Biochemistry 46 2007 6308
76. X. Wang, T. Zhao, and W. Huang Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors Stem Cells 27 2009 3021
77. W. Chang, B.W. Song, and S. Lim Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury Stem Cells 27 2009 2283
78. L.E. Otterbein, and A.M. Choi Heme oxygenase: Colors of defense against cellular stress Am J Physiol Lung Cell Mol Physiol 279 2000 L1029
79. C.H. Yeh, T.P. Chen, and Y.C. Wang HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-κB and AP-1 translocation following cardiac global ischemia and reperfusion J Surg Res 155 2009 147
80. Y.L. Tang, Y. Tang, and Y.C. Zhang Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector J Am Coll Cardiol 46 2005 1339
81. T. Tsubokawa, K. Yagi, and C. Nakanishi Impact of anti-apoptotic and -oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia Am J Physiol Heart Circ Physiol 2010
82. J.C. Reed Bcl-2 family proteins Oncogene 17 1998 3225
83. L.A. Kirshenbaum, and D. de Moissac The bcl-2 gene product prevents programmed cell death of ventricular myocytes Circulation 96 1997 1580
84. W. Li, N. Ma, and L.L. Ong Bcl-2 engineered MSCs inhibited apoptosis and improved heart function Stem Cells 25 2007 2118
85. K.A. Detillieux, F. Sheikh, and E. Kardami Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res 57 2003 8
86. H. Song, K. Kwon, and S. Lim Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions Mol Cells 19 2005 402
87. H. Marquardt, M.W. Hunkapiller, and L.E. Hood Rat transforming growth factor type 1: Structure and relation to epidermal growth factor Science 223 1984 1079
88. G. Sheng, J. Guo, and B.W. Warner Epidermal growth factor receptor signaling modulates apoptosis via p38α MAPK-dependent activation of Bax in intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol 293 2007 G599
89. D.A. Rappolee, D. Mark, and M.J. Banda Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping Science 241 1988 708
90. K. Satomura, A.R. Derubeis, and N.S. Fedarko Receptor tyrosine kinase expression in human bone marrow stromal cells J Cell Physiol 177 1998 426
91. K. Tamama, V.H. Fan, and L.G. Griffith Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells Stem Cells 24 2006 686
92. Y. Wang, P.R. Crisostomo, and M. Wang TGF-α increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms Am J Physiol Regul Integr Comp Physiol 295 2008 R1115
93. Y. Wang, B.R. Weil, and J.L. Herrmann MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells Am J Physiol Cell Physiol 297 2009 C1284
94. J.L. Herrmann, Y. Wang, and A.M. Abarbanell Preconditioning mesenchymal stem cells with transforming growth factor-α improves mesenchymal stem cell-mediated cardioprotection Shock 33 2010 24
95. G. Lu, H.K. Haider, and S. Jiang Sca-1+ stem cell survival and engraftment in the infarcted heart: Dual role for preconditioning-induced connexin-43 Circulation 119 2009 2587
96. J.Y. Hahn, H.J. Cho, and H.J. Kang Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction J Am Coll Cardiol 51 2008 933